Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
NAPCO Security Technologies to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020
-
Cabaletta Bio Reports Second Quarter 2020 Financial Results and Provides Business Update
-
Aptose Biosciences to Present at Canaccord Genuity 40th Annual Growth Conference
-
Cabaletta Bio Reports Second Quarter 2020 Financial Results and Provides Business Update
-
Cubic to Participate in Canaccord Genuity 40th Annual Growth Conference
-
Zynerba Pharmaceuticals to Present at the Virtual 40th Annual Canaccord Genuity Growth Conference
-
GAN to Participate in Upcoming Investor Conferences
-
Milestone Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference
-
BioXcel Therapeutics to Participate in the Canaccord Genuity 40th Annual Growth Conference
-
Blue Apron (APRN) Prices 4M Share Offering at $9.25/Share
-
MiX Telematics to Present at the Canaccord Genuity Growth Conference
-
Blue Apron Announces Pricing of Public Offering of Class A Common Stock
-
Acutus Medical Announces Pricing of Initial Public Offering
-
Canaccord Genuity Group Inc. Reports First Quarter Fiscal 2021 Results
-
Leaf Group to Participate in the Canaccord Genuity 40th Annual Growth Conference
-
Leaf Group to Participate in the Canaccord Genuity 40th Annual Growth Conference
-
Blue Apron (APRN) Announces 4M Share Proposed Public Offering of Class A Common Stock
-
Atreca to Present at Two Upcoming Virtual Healthcare Conferences
-
Blue Apron Announces Proposed Public Offering of Class A Common Stock
-
Atreca to Present at Two Upcoming Virtual Healthcare Conferences
-
Sesen Bio to Present Regulatory and Business Development Update at the Canaccord Genuity 40th Annual Growth Conference
-
Bicycle Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conference
-
REPAY to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Tactile Medical to Present at the Canaccord Genuity 40th Annual Global Growth Conference
-
Xencor to Present at Upcoming Investor Conferences
-
BigCommerce (BIGC) IPO Opens 183% Higher
-
Net Asset Value(s)
-
Trupanion, Inc. (TRUP) PT Raised to $62 at Canaccord Genuity, Following Earnings
-
Vapotherm (VAPO) PT Raised to $54 at Canaccord Genuity, Following Earnings
-
Coupa Software to Participate Virtually in the Canaccord Genuity 40th Annual Growth Conference
-
Ameresco to Participate at Upcoming Conference
-
EXFO to present at Canaccord Genuity's virtual conference
-
Trupanion Announces Virtual Participation at the Canaccord Genuity 40th Annual Growth Conference
-
Option Care Health to Participate in the Canaccord Genuity Virtual Growth Conference
-
Option Care Health to Participate in the Canaccord Genuity Virtual Growth Conference
-
Savara to Present at the 40th Annual Canaccord Genuity Global Growth Conference to be Held Virtually
-
Entasis Therapeutics to Participate in Upcoming Healthcare Conferences
-
Kaleido Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Amplyx Pharmaceuticals Announces Participation in Multiple Upcoming Investor Conferences
-
Entasis Therapeutics to Participate in Upcoming Healthcare Conferences
-
Kaleido Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Green Dot (GDOT) PT Raised to $56 at Canaccord Genuity Following 2Q
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
-
Castle Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Bicycle Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
-
BigCommerce Holdings, Inc. (BIGC) Prices 9.019M Share IPO at $24/Sh
-
Top 3 Fintech Stocks To Buy In August 2020?

